Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $68.4M | $76.2M | $88.4M | $20.6M | $21.5M | |
| Gross Profit | $38.9M | $22.6M | $38.2M | $12.2M | -$3.8M | |
| Operating Income | -$128.2M | -$99.9M | -$81.1M | -$15.6M | -$32.4M | |
| EBITDA | -$118M | -$89.8M | -$72.3M | -$13M | -$30.5M | |
| Diluted EPS | -$0.61 | -$0.47 | -$0.33 | -$0.08 | -$0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $543.5M | $372.5M | $268.6M | $199.5M | $241.4M | |
| Total Assets | $580.3M | $443.3M | $334.2M | $265.3M | $290M | |
| Current Liabilities | $45.2M | $45.9M | $45.4M | $42.8M | $50.3M | |
| Total Liabilities | $129.1M | $99.6M | $76.8M | $83.4M | $86.2M | |
| Total Equity | $451.3M | $343.6M | $257.4M | $181.8M | $203.8M | |
| Total Debt | -- | $30.2M | $23.4M | $21M | $18.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$114.6M | -$51.7M | -$24.9M | -$7.9M | -$2.9M | |
| Cash From Investing | $70.4M | -$4.8M | -$2.7M | -$413K | -$1M | |
| Cash From Financing | $365K | -- | $78M | -- | -- | |
| Free Cash Flow | -$120M | -$56.5M | -$27.5M | -$8.3M | -$3.9M | |
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
In the current month, BFLY has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BFLY average analyst price target in the past 3 months is $4.19.
According to analysts, the consensus estimate is that Butterfly Network, Inc. share price will rise to $4.19 per share over the next 12 months.
Analysts are divided on their view about Butterfly Network, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Butterfly Network, Inc. is a Sell and believe this share price will drop from its current level to $3.25.
The price target for Butterfly Network, Inc. over the next 1-year time period is forecast to be $4.19 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Butterfly Network, Inc. is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
You can purchase shares of Butterfly Network, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Butterfly Network, Inc. shares.
Butterfly Network, Inc. was last trading at $4.07 per share. This represents the most recent stock quote for Butterfly Network, Inc.. Yesterday, Butterfly Network, Inc. closed at $3.87 per share.
In order to purchase Butterfly Network, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.